Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.
D024506:5' Flanking Region / Q000235:genetics; D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D001483:Base Sequence; D001681:Biological Assay; D045744:Cell Line, Tumor; D003001:Cloning, Molecular; D004195:Disease Models, Animal; D015870:Gene Expression; D015972:Gene Expression Regulation, Neoplastic; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics*; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D009368:Neoplasm Transplantation; D011401:Promoter Regions, Genetic / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis; D020218:Response Elements / Q000235:genetics; D017422:Sequence Analysis, DNA; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000378:metabolism; D001749:Urinary Bladder Neoplasms / Q000628:therapy*; D060170:Uroplakin II
D008565:Membrane Proteins; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; C554658:UPK2 protein, human; C554659:Upk2 protein, mouse; D060170:Uroplakin II